Market Closed -
Nyse
04:00:02 2024-04-18 pm EDT
5-day change
1st Jan Change
139.1
USD
+0.51%
-0.01%
+12.53%
Ex-dividend day
A dividend is removed today from 's share.
AptarGroup Keeps Quarterly Cash Dividend at $0.41 a Share, Payable May 16 to Holders of Record April 25
Apr. 11
MT
AptarGroup, Inc. Declares Quarterly Dividend, Payable on May 16, 2024
Apr. 11
CI
Aptargroup Insider Sold Shares Worth $284,906, According to a Recent SEC Filing
Mar. 12
MT
Aptargroup Insider Sold Shares Worth $499,932, According to a Recent SEC Filing
Mar. 12
MT
Wells Fargo Adjusts AptarGroup's Price Target to $160 From $157, Maintains Overweight Rating
Mar. 07
MT
Aptargroup Insider Sold Shares Worth $4,533,394, According to a Recent SEC Filing
Mar. 05
MT
Tanda, CEO of Aptar: Inflation less of a concern in the pharmaceutical sector
Feb. 12
MT
AptarGroup's Digital Health Business, Biogen to Develop Products for Neurological, Rare Diseases
Feb. 09
MT
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Feb. 09
MT
Transcript : AptarGroup, Inc., Q4 2023 Earnings Call, Feb 09, 2024
Feb. 09
AptarGroup Q4 Adjusted Earnings, Sales Rise; Sets Q1 Outlook
Feb. 08
MT
Earnings Flash (ATR) APTARGROUP Posts Q4 Revenue $838.5M, vs. Street Est of $842.5M
Feb. 08
MT
Earnings Flash (ATR) APTARGROUP Posts Q4 EPS $1.21, vs. Street Est of $1.12
Feb. 08
MT
Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on April 18, 2019.
Feb. 08
CI
AptarGroup, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
Feb. 08
CI
AptarGroup Maintains Quarterly Dividend at $0.41 per Share, Payable Feb. 22 to Stockholders of Record Feb. 1
Jan. 18
MT
AptarGroup, Inc. Declares Quarterly Cash Dividend, Payable on February 22, 2024
Jan. 18
CI
Transcript : AptarGroup, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 10:30 AM
Jan. 11
North American Morning Briefing : S&P 500 Futures -2-
Jan. 04
DJ
Baird Upgrades AptarGroup to Outperform From Neutral, Raises Price Target to $150 From $125
Jan. 03
MT
AptarGroup, Inc. Wins US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers
Dec. 04
CI
Aptargroup Insider Sold Shares Worth $306,447, According to a Recent SEC Filing
Nov. 27
MT
AptarGroup, Inc. Seeks M&A
23-10-26
CI
Transcript : AptarGroup, Inc., Q3 2023 Earnings Call, Oct 26, 2023
23-10-26
AptarGroup Posts Higher Q3 Adjusted Earnings, Sales; Issues Q4 EPS Outlook
23-10-25
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.
More about the company
Last Close Price
139.1
USD
Average target price
147.6
USD
Spread / Average Target
+6.08%
Consensus
1st Jan change
Capi.
+12.53% 9.2B -7.78% 12.85B -16.43% 6.53B -13.38% 1.41B +28.00% 1.42B +7.09% 1.32B +30.64% 1.29B -20.63% 1.06B +25.03% 883M +8.80% 784M
Plastic Containers & Packaging
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1